Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Malaria vaccines: triumphs or tribulations?

W R Ballou¹, K E Kester, J A Stoute

¹Department of Immunology, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA. ballouw@medimmune.com

|March 4, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults.

Vaccine·2024

Same author

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype.

Vaccine·2018

Same author

Dual role of erythrocyte complement receptor type 1 in immune complex-mediated macrophage stimulation: implications for the pathogenesis of Plasmodium falciparum malaria.

Clinical and experimental immunology·2011

Same author

Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.

Vaccine·2009

Same author

The development of the RTS,S malaria vaccine candidate: challenges and lessons.

Parasite immunology·2009

Same author

Distinct pattern of class and subclass antibodies in immune complexes of children with cerebral malaria and severe malarial anaemia.

Parasite immunology·2008

Developing effective malaria vaccines is crucial for global control. This research highlights pre-erythrocytic vaccines, like RTS,S, which aim to prevent infection and show promising results in human trials.

Area of Science:

Vaccinology
Infectious Disease Control
Parasitology

Background:

Malaria remains a significant global health challenge, necessitating novel control strategies.
Existing interventions face challenges in eradicating the disease.
Development of a safe and effective malaria vaccine is a key objective.

Purpose of the Study:

To discuss the conceptual framework for malaria vaccine development.
To identify challenges associated with various vaccine approaches.
To emphasize the importance of pre-erythrocytic malaria vaccines.

Main Methods:

Review of conceptual frameworks for malaria vaccine design.
Analysis of challenges in vaccine development.
Examination of pre-erythrocytic vaccine strategies.

Related Experiment Videos

Discussion of recent clinical trial data for vaccine candidates.

Main Results:

Pre-erythrocytic vaccines target the initial infection stage, offering protection beyond preventing clinical symptoms.
The RTS,S vaccine candidate has demonstrated encouraging results in human subjects.
Challenges in malaria vaccine development are significant but surmountable with focused research.

Conclusions:

Pre-erythrocytic malaria vaccines represent a promising strategy for disease control.
The RTS,S vaccine shows potential as an effective tool against malaria infection.
Continued research and development are vital for a successful global malaria vaccine.